EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
147 hedge funds and large institutions have $1.36B invested in Eagle Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 51 increasing their positions, 49 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1% less funds holding
Funds holding: 149 → 147 (-2)
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
Holders
147
Holding in Top 10
3
Calls
$12.2M
Puts
$3.85M
Top Buyers
| 1 | +$100M | |
| 2 | +$59.3M | |
| 3 | +$19M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$17.4M |
| 5 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$10.8M |
Top Sellers
| 1 | -$39.5M | |
| 2 | -$24.9M | |
| 3 | -$17.4M | |
| 4 |
CM
Castleark Management
Chicago,
Illinois
|
-$9.24M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$8.8M |